Hazardous Pharmaceutical Supply and Packaging

This contract entails the procurement, packaging, and labeling of Tetracane Hydrochloride, a hazardous ophthalmic anesthetic, ensuring adherence to all applicable federal, military, and safety regulations. The scope emphasizes stringent compliance due to the chemical’s hazardous nature and its use in sensitive medical applications, particularly within military contexts. The contract is issued as a subcontract under the NAICS code 325412, which corresponds to pharmaceutical manufacturing, and is managed by the Medical Supply Chain Pharmacy FSA under the Department of Defense. The work is to be performed primarily at Fort Bragg, with the solicitation posted on May 27, 2026, and a response deadline set for June 2, 2026. Although no specific type of set-aside or organization type is designated, the contract calls for providers capable of meeting rigorous standards in hazardous pharmaceutical supply, highlighting the critical nature of the product and its handling requirements within military medical logistics.